Guidelines for the management of acne vulgaris in adolescents

Pediatric Drugs

Volumn 5, Issue 5, 2003, Pages 301-313

  Goulden, Victoria ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYPROTERONE ACETATE; DOXYCYCLINE; EMLA; ERYTHROMYCIN; ETHINYLESTRADIOL; ISOTRETINOIN; LIDOCAINE; LYMECYCLINE; MINOCYCLINE; OXYTETRACYCLINE; POLYURETHAN; PREDNISOLONE; PSEUDOMONIC ACID; RETINOIC ACID; RETINOID; TETRACYCLINE; TRIAMCINOLONE ACETONIDE; TRIMETHOPRIM; ZINC;

ABDOMINAL PAIN; ACNE VULGARIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTHRALGIA; BACTERIAL INFECTION; BONE DISEASE; CAUTERIZATION; CHEILITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVITIS; CORNEA OPACITY; CORNEA ULCER; CRYOTHERAPY; DEPRESSION; DERMATITIS; DIARRHEA; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG POTENTIATION; DYSLIPIDEMIA; ECZEMA; ENTERITIS; EPILEPSY; FATIGUE; FETUS MALFORMATION; GASTROINTESTINAL DISEASE; GRANULOMA; HAIR DISEASE; HAIR LOSS; HEADACHE; HORMONAL THERAPY; HUMAN; HYPEROSTOSIS; HYPERPIGMENTATION; INTRACRANIAL HYPERTENSION; IRRITABILITY; KERATITIS; LETHARGY; LEUKOPENIA; LIVER TOXICITY; MEGALOBLASTIC ANEMIA; MOOD DISORDER; MYALGIA; NAUSEA; NEPHROTOXICITY; NIGHT BLINDNESS; ONYCHOLYSIS; OSTEOPOROSIS; PHOTOSENSITIVITY DISORDER; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; RASH; REVIEW; SCAR FORMATION; SKIN ALLERGY; SKIN DISEASE; SKIN IRRITATION; SKIN PIGMENTATION; SOCIAL PSYCHOLOGY; SUICIDAL BEHAVIOR; TENDINITIS; TERATOGENICITY; THROMBOCYTOPENIA; TOOTH COLOR; TOOTH DISEASE; TREATMENT INDICATION; URTICARIA; VAGINA CANDIDIASIS; VESTIBULAR DISORDER; VISUAL IMPAIRMENT; XERODERMA PIGMENTOSUM; XEROPHTHALMIA;

EID: 0037565223     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200305050-00003     Document Type: Review

References (85)

1. Lello J, Pearl A, Arroll B, et al. Prevalence of acne vulgaris in Auckland senior high school students. NZ Med J 1995; 108: 287-9
2. Lucky AW, Biro FM, Huster FA. Ache vulgaris in early adolescent boys: correlation between pubertal maturation and age. Arch Dermatol 1991; 172: 210-6
3. Rademaker M, Gariosch JJ, Simpson NB. Acne in schoolchildren: no longer a cause for concern for dermatologists. BMJ 1989; 298: 1217-9
4. Kligman AM. An overview of acne. J Invest Dermatol 1974; 62: 268-87
5. Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990; 15: 374-7
6. Holland KT. The role of bacteria in acne vulgaris; a new approach. Clin Exp Dermatol 1978; 3: 263-7
7. Cunliffe WJ, Shuster S. The rate of sebum excretion in men. Br J Dermatol 1969; 81: 697-704
8. Swale V, Sasieni P, Macgregor A, et al. Heretability of common skin diseases using the twin model: a UK twin study. Br J Dermatol 1998; 139: 15-6
9. Gloor M, Hubscher M, Friederich HL. External treatment of acne vulgaris using tetracycline and estrogen [in German]. Hautarzt 1974; 25: 391-4
10. Fulton JE, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris. JAMA 1969; 210: 2071-4
11. Layton AM. Psychological aspects of ache vulgaris. J Cutan Med Surg 1998; 2 Suppl. 3: 19-23
12. Finlay AY. Khan GK. Dermatology life quality index (DLQI); a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6
13. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1-3
14. Layton AM, Seukeran DC, Cunliffe WJ. Scarred for life. Dermatology 1997; 195: 15-21
15. Burke BM. Cunliffe WJ. The assessment of acne vulgaris: the Leeds technique. Br J Dermatol 1984; 111: 82-93
16. Nacht S, Gans EH, McGinley KJ, et al. Comparative activity of benzoyl peroxide and hexachlorophene: in vivo studies against propionibacterium acnes in humans. Arch Dermatol 1983; 119: 577-9
17. Fulton JE, Farzad-Bakshandeth A. Studies on the mechanism of action of topical benzoyl peroxide in ache vulgaris. J Cutan Path 1974; 1: 191-200
18. Hamstein WF, Tegetmeyer L, Ziegler V. Allergic and irritant potential of benzoyl peroxide. Contact Dermatitis 1985; 13: 252-7
19. Holland KT, Bojar RA. Antimicrobial effects of azaleic acid. J Dermatol Treat 1993; 4 Suppl. 1: S8-11
20. Mayer De Dilva A, Gollnick H, Detmar M, et al. Effects of azaleic acid on sebaceous glands, sebum excretion rate and keratinisation patterns in human skin. Acta Derm Venereol (Stockh) 1979; 143: 20-30
21. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris with vehicle and topical tretinoin. Acta Derm Venereol (Stockh) 1989; 143: 35-9
22. Eady EA, Hope JH, Jones DN, et al. Topical antibiotics for the treatment of acne: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990; 1: 215-26
23. Thomas DR, Raimer S. Smith BE. Comparison of topical erythromycin 1.5% solution vs topical clindamycin phosphate 1% solution in the treatment of acne vulgaris. Cutis 1982; 29: 624-32
24. Esterley NB, Furey NL, Flaragan LE. The effect of antimicrobiological agents on leukocytes chemotaxis. J Invest Dermatol 1978; 70: 51-5
25. Eady EA, Jones CE, Tipper JL. et al. Antibiotic resistant propionibacteria in acne: need for policy for antibiotic usage. BMJ 1993; 306: 555-6
26. Chalker DK, Shalita AR, Smith JG, et al. A double blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983; 9: 933-6
27. Christophers E. Wolfe HH. Effect of vitamin A acid on skin: in vivo and in vitro Studies. Acta Derm Venereol (Stockh) 1975; 74: 42-53
28. Leyden J. Rational therapy for acne vulgaris: an update on topical treatment. J Am Acad Dermatol 1986; 15: 907-15
29. Shalita AR, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicentre trial. J Am Acad Dermatol 1999; 34: 482-5
30. Schefer H. Penetration and percutaneous absorption of topical retinoids: a review. Skin Pharmacol 1993; 6: 17-23
31. Rietschel R, Duncan BS. Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 1983; 22: 41-3
32. Mills OH, Kligman AM. Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol (Stockh) 1978; 58: 555-7
33. Tucker SB, Tousend R, Cochrane R, et al. Comparison of topical clindamycin phosphate, benzoyl peroxide and a combination of the two in the treatment of ache vulgaris. Br J Dermatol 1984; 110: 487-92
34. Feucht CL, Allen BS. Chalker DK, et al. Topical erythromycin with zinc in acne: a double blind controlled study. J Am Acad Dermatol 1980; 3: 483-91
35. Hurwitz S. Combined effect of vitamin A acid and benzoyl peroxide in the treatment of acne. Cutis 1976; 17: 585-90
36. Marples RR, Kligman AM. Ecological effects of oral antibiotics on the microflora of human skin. Arch Dermatol 1971; 103: 148-53
37. Cunliffe WJ, Cleydon AD, Gould D, et al. Acne vulgaris - its aetiology and treatment: a review. Clin Exp Dermatol 1981; 6: 461-9
38. Leyden JJ. Absorption of minocycline hydrochloride and tetracycline hydrochloride. J Am Acad Dermatol 1985; 12: 308-12
39. Bernier C, Dreno B. Minocycline. Ann Dermatol Venereol 2001; 128: 627-37
40. Knaggs HE, Layton AM, Cunliffe WJ. The role of oral minocycline and erythromycin in tetracycline resistant acne: a retrospective study and a review. J Dermatol Treat 1993; 4: 53-6
41. Harrison TV. A comparison of doxycycline and minocycline in the treatment of acne vulgaris. Clin Exp Dermatol 1988; 13: 242-4
42. Bottomley WW, Cunliffe WJ. Oral trimethoprim as a third line antibiotic treatment in the management of acne vulgaris. Dermatology 1993; 187: 193-6
43. Eady EA, Jones CE, Gardner KJ, et al. Tetracycline resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br J Dermatol 1993; 128: 556-60
44. Miller YW, Eady EA, Vyakrnam S, et al. One in two close contacts of antibiotic treated acne patients carry resistant propionibacteria on their skin surface [abstract]. J Invest Dermatol 1997; 108: 379
45. Eady EA, Cove JH, Holland KT. et al. Erythromycin resistant propionibacteria in antibiotic resistant acne. Br J Dermatol 1989; 121: 51-7
46. Eady EA, Farmery MR, Ross JI, et al. Effect of benzoyl peroxide and erythromycin alone and in combination against antibiotic sensitive and resistant skin bacteria from acne patients. Br J Dermatol 1994; 131: 331-6
47. Delaney TJ, Leopard BJ, Macdonald DM. Effects of long term treatment with tetracycline. Acta Derm Venereol (Stockh) 1975; 54: 487-9
48. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline: a dose related phenomenon. Clin Exp Dermatol 1993; 18: 425-7
49. Systemic antibiotics for the treatment of acne vulgaris: efficacy and safety. Ad Hoc Committee Report. Arch Dermatol 1975; 111: 1630-6
50. Ray WA, Federspiel CF, Schaffner W. Prescribing of tetracycline to children less than 8 years. JAMA 1977; 237: 2069-74
51. Salter AJ. Trimethoprim/sulfamethoxazole: an assessment of more than twelve years use. Rev Infect Dis 1982; 4: 196-236
52. Somech R, Arav-Boger R, Assia A, et al. Complications of minocycline therapy for ache vulgaris: case report and review of the literature. Pediatr Dermatol 1999; 16: 469-72
53. Fanning WL, Gump DW, Sofferman RA. Side effects of minocycline; a double blind study. Antimicrob Agents Chemother 1977; 11: 712-7
54. Green D, Freedman KJ. Treatment of minocycline induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature. J Am Acad Dermatol 2001; 44: 342-7
55. Hanstead B, Reymann F. Cyproterone acetate in the treatment of acne vulgaris in adult females. Dermatologica 1982; 164: 117-26
56. Thiboutot DM, Knaggs HE, Gilliland K, et al. Activity of type 1 5α-reductase is greater in the follicular infundibulum compared with the epidermis. Br J Dermatol 1997; 136: 166-71
57. Greenwood R, Brummitt L, Burke B, et al. Acne: a double blind clinical and laboratory trial of tetracycline, oestrogen, cyproterone acetate and combined treatment. BMJ 1985; 291: 1231-5
58. Layton AM, Cunliffe WJ. Guidelines for the optimal use of isotretinoin in acne. J Am Acad Dermatol 1992; 27 (6 Pt 2): S2-7
59. Cunliffe WJ, Van De Kerkhof PCM, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351-7
60. Cunliffe WJ. Treatment of acne. In: Marks R, editor. Acne and related disorders. London: M Dunitz, 1989: 266-76
61. Colburn WA, Gibson DM, Wiens RE, et al. Food increases the bioavailability of isotretinoin. J Clin Pharmacol 1983; 23: 534-9
62. Layton AM, Knaggs HE, Taylor J, et al. Isotretinoin for acne vulgaris - 10 years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292-6
63. Harms M, Masooye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age related: a long term follow up study. Dermatologica 1986; 172: 148-53
64. Clark SM, Cunliffe WJ. Acne flare and isotretinoin: incidence and treatment [abstract]. Br J Dermatol 1995; 133: 26
65. Karvone S. Acne fulminans: report of clinical findings and treatment of 24 patients. J Am Acad Dermatol 1993; 28: 572-9
66. Chivot M, Midoun H. Isotretinoin and acne: a study of relapses. Dermatologica 1990; 180: 240-3
67. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45: S150-7
68. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985; 313: 837-41
69. Dai WS, Hus MA, Itri LM. Safety of pregnancy after discontinuation of isotretinoin. Arch Dermatol 1989; 125: 362-5
70. Giovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol 2001; 45 Suppl. 5: S176-82
71. Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: is there a causal link. J Am Acad Dermatol 2001; 45 Suppl. 5: S168-75
72. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-50
73. Staels B. Regulation of lipid and lipoprotein metabolism by retinoids. J Am Acad Dermatol 2001; 45 Suppl. 5: S158-67
74. Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthetic. B r J Dermatol 1991; 125: 256-9
75. Orentreich N, Durr NP, Frank SB, editors. Acne. New York: Yorke Medical Books, 1979
76. Yarborough JM. Scar revision by dermabrasion. In: Roenigk RK, Roenigk HH, editors. Dermatological surgery. New York: Marcel Dekker, 1989: 909-33
77. Sneddon J, Sneddon I. Acne excoriée; a protective device. Clin Exp Dermatol 1983; 8: 65-8
78. Kent A, Drummond LM. Acne excoriée: a case report using habit reversal. Clin Exp Dermatol 1989; 14: 163-4
79. Cotterill JA. Dermatological non-disease. Dermatol Clin 1996; 14: 439-45
80. Carvone SL, Rasane L, Cunliffe WJ, et al. Delayed hypersensitivity to propionibacteria acnes in patients with severe nodular acne and acne fulminans. Dermatology 1994; 189: 344-9
81. Michelson HE, Allen PK. Acne conglobata. Arch Dermatol 1931; 23: 49-67
82. Plewig G, Jansen T. Acneiform dermatoses. Dermatology 1998; 196: 102-7
83. Kligman AM, Mills OH. Acne cosmetica. Arch Dermatol 1970; 10: 843-50
84. Kligman AM. A critical look at acne cosmetica. J Cutan Aging Cosmet Dermatol 1988; 1: 109-12
85. Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch Dermatol 1970; 101: 580-4